Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 5/20 | 0.61 |
| ▸ | FYN | P06241 | 3/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.56 |
| ▸ | MTOR | P42345 | 3/20 | 0.56 |
| ▸ | EGFR | P00533 | 3/20 | 0.54 |
| ▸ | LCK | P06239 | 2/20 | 0.54 |
| ▸ | JAK3 | P52333 | 2/20 | 0.54 |
| ▸ | BTK | Q06187 | 2/20 | 0.54 |
| ▸ | ITK | Q08881 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.53 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.53 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.53 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.53 |
| ▸ | PRKDC | P78527 | 2/20 | 0.53 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14471387 | 0.93 | SRC (0.64) | SRCFYNHDAC1MTOREGFR | |
| SCHEMBL14471386 | 0.85 | PIK3CD (0.63) | SRCFYNEGFRBTKPIK3CD | |
| SCHEMBL29677976 | 0.84 | SRC (0.65) | SRCFYNMTOREGFRBTK | |
| SCHEMBL14086355 | 0.84 | SRC (0.66) | SRCFYNEGFRKDM4EPIK3CD | |
| SCHEMBL28477160 | 0.81 | BTK (0.66) | HDAC1MTOREGFRLCKJAK3 | |
| SCHEMBL17267665 | 0.80 | HDAC1 (0.47) | SRCFYNHDAC1MTOREGFR | |
| SCHEMBL15826975 | 0.79 | FYN (0.68) | SRCFYNEGFRBTKKDM4E | |
| SCHEMBL15826968 | 0.78 | PIK3CD (0.73) | SRCFYNMTOREGFRBTK | |
| SCHEMBL12551792 | 0.78 | SRC (0.64) | SRCFYNEGFRBTKPIK3CD | |
| SCHEMBL19282991 | 0.78 | MTOR (0.82) | HDAC1MTORPIK3CDPIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070173437-A1 | BISUBSTRATE INHIBITORS OF PROTEIN TYROSINE KINASES AS THERAPEUTIC AGENTS | RHODE ISLAND BOARD OF EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS | 2007-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173437-A1 | BISUBSTRATE INHIBITORS OF PROTEIN TYROSINE KINASES AS THERAPEUTIC AGENTS | DSTYK, SRC, PTK2B | SRC 2/4885FYN 83/4885HDAC1 4816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.